SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]:
SEC Accession No. 0001213900-23-043689
Filing Date
2023-05-30
Accepted
2023-05-30 08:00:11
Documents
6
Period of Report
2023-05-30

Document Format Files

Seq Description Document Type Size
1 REPORT OF FOREIGN PRIVATE ISSUER ea179273-6k_altamira.htm 6-K 11368
2 NOTICE TO SHAREHOLDERS DATED MAY 30, 2023 ea179273ex99-1_altamira.htm EX-99.1 35722
3 PROXY CARD FOR THE ANNUAL GENERAL MEETING OF SHAREHOLDERS ea179273ex99-2_altamira.htm EX-99.2 1402
4 GRAPHIC ex99-1_001.jpg GRAPHIC 9972
5 GRAPHIC ex99-2_001.jpg GRAPHIC 181799
6 GRAPHIC ex99-2_002.jpg GRAPHIC 143404
  Complete submission text file 0001213900-23-043689.txt   511828
Mailing Address CLARENDON HOUSE 2 CHURCH STREET HAMILTON HM 11 D0 00000
Business Address CLARENDON HOUSE 2 CHURCH STREET HAMILTON HM 11 D0 00000 41 (0) 41 729 71 94
Altamira Therapeutics Ltd. (Filer) CIK: 0001601936 (see all company filings)

IRS No.: 000000000 | State of Incorp.: D0 | Fiscal Year End: 1231
Type: 6-K | Act: 34 | File No.: 001-36582 | Film No.: 23971450
SIC: 2834 Pharmaceutical Preparations